The promise of automated liver disease risk stratification in primary care

Affiliations

¹ Transplantation and Liver Surgery Unit, Helsinki University Hospital and University of Helsinki, 00029 HUS Helsinki, Finland. Electronic address: fredrik.aberg@helsinki.fi.
² School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

Comment

Fredrik Åberg et al. Lancet Gastroenterol Hepatol. 2025 Jan.

. 2025 Jan;10(1):5-7.

doi: 10.1016/S2468-1253(24)00316-9.

¹ Transplantation and Liver Surgery Unit, Helsinki University Hospital and University of Helsinki, 00029 HUS Helsinki, Finland. Electronic address: fredrik.aberg@helsinki.fi.
² School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Department of Medicine, Kuopio University Hospital, Kuopio, Finland.

No abstract available

Conflict of interest statement

We declare no competing interests.

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.
Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M. Lindvig KP, et al. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):55-67. doi: 10.1016/S2468-1253(24)00274-7. Lancet Gastroenterol Hepatol. 2025. PMID: 39674225